News GeneDx Holdings Corp.

Equities

WGS

US81663L2007

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
11.08 ^USD	-0.81%		+14.94%	+302.91%

23/04	Genedx Announces Partnership with Komodo Health to Expand Access to World?S Largest Rare Disease Dataset	CI
15/04	Goldman Sachs Adjusts GeneDx Holdings Price Target to $11 From $6, Maintains Neutral Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset	23/04	AQ
Genedx Announces Partnership with Komodo Health to Expand Access to World?S Largest Rare Disease Dataset	23/04	CI
Goldman Sachs Adjusts GeneDx Holdings Price Target to $11 From $6, Maintains Neutral Rating	15/04	MT
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024	05/04	AQ
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics	14/03	AQ
GeneDx to Participate in 44th Annual Cowen Health Care Conference	27/02	AQ
Health Care Down on a Mixed Growth View -- Health Care Roundup	22/02	DJ
Earnings Flash (WGS) GENEDX HOLDINGS Posts Q4 Revenue $57.4M	21/02	MT
Transcript : GeneDx Holdings Corp., Q4 2023 Earnings Call, Feb 20, 2024	21/02
GeneDx Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	21/02	CI
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024	21/02	AQ
GeneDx Holdings Corp. Provides Earnings Guidance for the Full Year of 2024	21/02	CI
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024	02/02	AQ
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	25/01	AQ
GeneDx Shares Gain After Preliminary Q4 Revenue Outlook	09/01	MT
GeneDx Announces Preliminary 2023 Financial Results	08/01	AQ
Genedx Holdings Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023	08/01	CI
GeneDx Holdings Corp.(NasdaqGS:WGS) dropped from S&P Global BMI Index	18/12	CI
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy	01/12	AQ
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference	29/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GeneDx Holdings Corp.

Equities

WGS

US81663L2007

Summary

Filters